Production of pilot lots of inactivated influenza vaccine in response to a pandemic threat: an interim biosafety risk assessment.
D002170:Canada / Q000453:epidemiology; D004196:Disease Outbreaks; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000276:immunology; D006801:Humans; D009980:Influenza A virus / Q000235:genetics / Q000276:immunology; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control*; D016865:Reassortant Viruses / Q000235:genetics / Q000276:immunology; D018570:Risk Assessment; D015164:Vaccines, Inactivated
D019267:Hemagglutinin Glycoproteins, Influenza Virus; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated